<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cells c-myc is often translocated in proximity to the Emu enhancer of the Ig gene locus </plain></SENT>
<SENT sid="1" pm="."><plain>This translocation causes c-myc hyperexpression and an increase in the cells' proliferative capacity </plain></SENT>
<SENT sid="2" pm="."><plain>A <z:chebi fb="0" ids="48021">peptide nucleic acid</z:chebi> (<z:chebi fb="3" ids="48021">PNA</z:chebi>) complementary to enhancer Emu intronic sequence (PNAEmu), linked to a nuclear localization signal (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NLS</z:e>), selectively and specifically blocks the expression of the c-myc oncogene under Emu control in vitro, suggesting potential therapeutic use </plain></SENT>
<SENT sid="3" pm="."><plain>To explore this issue further, we have determined the pharmacokinetics of (14)C-labeled PNAEmu in <z:mp ids='MP_0002536'>SCID</z:mp> mice where a human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> is established by inoculation of cells from a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell line </plain></SENT>
<SENT sid="4" pm="."><plain>The data demonstrate that the compound has a relatively long life in vivo in tissues and, in particular, in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> mass </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, in this animal model, PNAEmu shows low or no toxicity </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these results are in favor of a successful preclinical application in a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> animal model of a <z:chebi fb="3" ids="48021">PNA</z:chebi> targeting a regulatory, nontranscribed DNA sequence that can selectively inhibit the hyperexpression of a translocated gene linked to neoplastic cell expansion </plain></SENT>
</text></document>